Travere Therapeutics Inc (RTRX) Ownership

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Travere Therapeutics Inc (RTRX), owning a total of 7.8 million shares. Combined, the top 29 institutional holders of RTRX own 124.87% of the company with a total of 86.7 million shares.

In the latest ownership report on March 31st 2024, the top 29 institutional holders increased their combined ownership of RTRX by 4.4 million shares. 12 institutions bought 6,153,930 total additional shares and increased their ownership by an average of 31.98%. However 6 institutions sold 1,757,576 total shares and decreased their ownership by an average of 10.72%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Travere Therapeutics increased by a net total of 4,396,354 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc10.242%-1.529%7,796,766-121,0942024-03-31
Armistice Capital, LLC9.852%1.571%7,500,000116,0002024-03-31
Deep Track Capital, LP9.681%0.000%7,370,00002024-03-31
State Street Corporation8.681%23.473%6,608,6961,256,3512024-03-31
Vanguard Group Inc8.231%13.611%6,265,829750,6862024-03-31
Macquarie Group Ltd6.060%-2.817%4,613,059-133,7172024-03-31
Morgan Stanley - Brokerage Accounts4.634%-14.715%3,527,620-608,6702024-03-31
Rock Springs Capital Management LP4.499%23.575%3,424,818653,3722024-03-31
Renaissance Technologies Corp3.759%-7.108%2,862,014-219,0002024-03-31
Deutsche Bank AG3.155%0.034%2,401,5738062024-03-31
Pictet Asset Manangement SA2.941%-5.408%2,238,868-128,0102024-03-31
Millennium Management LLC2.892%70.088%2,201,929907,3432024-03-31
Kynam Capital Management, LP2.627%0.000%2,000,00002024-03-31
D. E. Shaw & Co LP2.423%87.553%1,844,663861,1182024-03-31
Emerald Advisers, LLC2.298%67.223%1,749,401703,2522024-03-31
Bank of America Corp2.246%5.437%1,709,63388,1662024-03-31
Finepoint Capital LP2.166%14.903%1,649,221213,9002024-03-31
Geode Capital Management, LLC2.050%2.573%1,560,88839,1582024-03-31
Emerald Mutual Fund Advisers Trust1.745%73.735%1,328,381563,7782024-03-31
Jacobs Levy Equity Management, Inc.1.477%-32.725%1,124,685-547,0852024-03-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc10.242%-1.529%7,796,766-121,0942024-03-31
Armistice Capital, LLC9.852%1.571%7,500,000116,0002024-03-31
Deep Track Capital, LP9.681%0.000%7,370,00002024-03-31
State Street Corporation8.681%23.473%6,608,6961,256,3512024-03-31
Vanguard Group Inc8.231%13.611%6,265,829750,6862024-03-31
RA Capital Management, LLC9.080%11.262%4,635,687469,2342020-06-30
Macquarie Group Ltd6.060%-2.817%4,613,059-133,7172024-03-31
Morgan Stanley - Brokerage Accounts4.634%-14.715%3,527,620-608,6702024-03-31
Rock Springs Capital Management LP4.499%23.575%3,424,818653,3722024-03-31
Perceptive Advisors LLC6.347%12.091%3,240,112349,5042020-06-30
Renaissance Technologies Corp3.759%-7.108%2,862,014-219,0002024-03-31
Deutsche Bank AG3.155%0.034%2,401,5738062024-03-31
Pictet Asset Manangement SA2.941%-5.408%2,238,868-128,0102024-03-31
Manufacturers Life Insurance Co4.331%1.366%2,211,14129,7912020-09-30
Millennium Management LLC2.892%70.088%2,201,929907,3432024-03-31
Kynam Capital Management, LP2.627%0.000%2,000,00002024-03-31
D. E. Shaw & Co LP2.423%87.553%1,844,663861,1182024-03-31
Emerald Advisers, LLC2.298%67.223%1,749,401703,2522024-03-31
Bank of America Corp2.246%5.437%1,709,63388,1662024-03-31
Finepoint Capital LP2.166%14.903%1,649,221213,9002024-03-31
Geode Capital Management, LLC2.050%2.573%1,560,88839,1582024-03-31
Adage Capital Partners Gp LLC3.006%-6.118%1,534,500-100,0002020-09-30
Scopia Management Inc2.609%-25.408%1,332,150-453,7592020-09-30
Emerald Mutual Fund Advisers Trust1.745%73.735%1,328,381563,7782024-03-31
venBio Select Advisor LLC2.595%26.191%1,325,000275,0002020-09-30
Dimensional Fund Advisors, Inc.2.351%-1.672%1,200,266-20,4142020-09-30
Jacobs Levy Equity Management, Inc.1.477%-32.725%1,124,685-547,0852024-03-31
FMR Inc1.594%0.000%813,69902020-09-30
Goldman Sachs Group Inc1.303%-22.017%665,075-187,7742020-09-30

Mutual Fund Ownership

SPDR® S&P Biotech ETF is the biggest individual fund holder of Travere Therapeutics Inc (RTRX), owning a total of 4.8 million shares. Combined, the top 33 mutual fund holders of RTRX own 57.57% of the company with a total of 38.8 million shares.

In the latest ownership report on May 31st 2024, the top 33 fund holders increased their combined ownership of RTRX by 92 thousand shares. 2 funds bought 149,665 total additional shares and increased their ownership by an average of 3.46%. However 2 funds sold 57,819 total shares and decreased their ownership by an average of 0.72%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Travere Therapeutics increased by a net total of 91,846 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF6.298%-1.165%4,794,754-56,4962024-05-31
Vanguard Total Stock Mkt Idx Inv3.287%5.895%2,502,357139,3002024-05-31
Vanguard Institutional Extnd Mkt Idx Tr1.348%1.020%1,026,43510,3652024-05-31
Xtrackers MSCI World Swap ETF 1C0.767%0.000%584,17002024-05-31
Principal SmallCap Growth I Instl0.615%-0.282%468,335-1,3232024-05-31
State St Russell Sm/Mid Cp® Indx NL Cl C0.598%0.000%454,88502024-05-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF6.298%-1.165%4,794,754-56,4962024-05-31
Delaware Small Cap Core I4.684%0.000%3,566,03502024-04-30
Delaware US Small Cap Core Equity (SMA)4.684%-1.157%3,566,035-41,7362024-03-31
Macquarie US Small Cap Core Equity4.936%-8.157%2,519,680-223,7802020-09-30
Vanguard Total Stock Mkt Idx Inv3.287%5.895%2,502,357139,3002024-05-31
Aviva Investors GlConvtAbsRet I USD Acc2.889%-9.443%2,199,461-229,3512024-03-31
iShares Russell 2000 ETF2.181%0.766%1,660,25412,6282024-05-30
HBM Healthcare Investments AG Ord1.970%107.126%1,500,000775,8042024-03-31
Janus Henderson Global Life Sciences D2.248%-0.423%1,147,825-4,8792020-09-30
Janus Henderson Global Life Sciences2.248%-0.423%1,147,825-4,8792020-09-30
Pictet Biopharmaceutical Mother1.431%39.489%1,089,600308,4652023-10-13
Vanguard Institutional Extnd Mkt Idx Tr1.348%1.020%1,026,43510,3652024-05-31
Janus Henderson Glb Life Scn I2 USD1.672%5.215%853,51042,3042020-11-30
Vanguard Explorer Inv1.094%74.530%833,137355,7762024-03-31
Fidelity® Select Biotechnology1.594%0.000%813,699813,6992020-11-30
Vanguard Strategic Equity Inv1.026%53.246%780,844271,3062024-03-31
Fidelity Small Cap Index0.946%-3.287%719,951-24,4692024-03-31
Janus Henderson US Small Cap Growth1.236%0.000%630,773630,7732020-09-30
Janus Henderson Venture D1.236%0.000%630,773630,7732020-09-30
Vanguard Extended Market Index Investor1.215%-0.859%620,030-5,3702020-11-30
Xtrackers MSCI World Swap ETF 1C0.767%0.000%584,17002024-05-31
iShares Russell 2000 Growth ETF0.745%0.000%567,27602024-05-30
BlackRock Advantage Small Cap Core Instl0.733%0.000%558,19302024-04-30
Nuveen Quant Small Cap Equity R60.728%1.283%554,4007,0202024-04-30
iShares Biotechnology ETF0.699%-0.377%532,377-2,0122024-05-30
Direxion Daily S&P Biotech Bull 3X ETF0.636%0.000%483,87102024-05-30
Principal SmallCap Growth I Instl0.615%-0.282%468,335-1,3232024-05-31
State St Russell Sm/Mid Cp® Indx NL Cl C0.598%0.000%454,88502024-05-31
iShares Nasdaq Biotechnology ETF0.869%-1.461%443,826-6,5802020-12-31
TIAA-CREF Quant Small-Cap Equity Instl0.826%-1.725%421,566-7,4002020-11-30
DFA US Small Cap I0.802%-3.354%409,323-14,2052020-11-30
BlackRock Health Sciences Trust II0.773%0.000%394,67402020-09-30
MEDICAL BioHealth EUR0.556%0.000%283,571283,5712020-11-30

Discussions

Please log in or register to share your thoughts.

gangganggang9/30/24 09:03pm

$RTRX Shorts talk the talk but cant walk the walk

0 Like Report
wsb_pro5/15/24 11:10pm

$RTRX gets me every time lol

0 Like Report